Showing results (121-130 of 221) with videos related to
Sort By:
Pageof 23
Blood|January 6, 2016
Impact of BCR-ABL transcript type on outcome in patients with chronic-phase CML treated with tyrosine kinase inhibitorsPreetesh Jain, Hagop Kantarjian, Keyur P Patel, et al.British Journal of Haematology|April 7, 2017
Characteristics, management, and outcomes of patients with follicular dendritic cell sarcomaPreetesh Jain, Sarah A Milgrom, Keyur P Patel, et al.European Journal of Haematology|February 1, 2018
Chronic lymphoproliferative disorder of NK-cells: A single-institution review with emphasis on relative utility of multimodality diagnostic toolsHabibe Kurt, Jeffrey L Jorgensen, Hesham M Amin, et al.Cancer|April 24, 2018
Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panelsCourtney D DiNardo, Mark J Routbort, Sarah A Bannon, et al.American Journal of Clinical Pathology|April 29, 2016
Identification of Factors Affecting the Success of Next-Generation Sequencing Testing in Solid TumorsRashmi S Goswami, Rajyalakshmi Luthra, Rajesh R Singh, et al.Cancer Cytopathology|October 29, 2020
Utilization of cytology smears improves success rates of RNA-based next-generation sequencing gene fusion assays for clinically relevant predictive biomarkersNisha S Ramani, Hui Chen, Russell R Broaddus, et al.Leukemia Research|November 9, 2015
Detectable FLT3-ITD or RAS mutation at the time of transformation from MDS to AML predicts for very poor outcomesTalha Badar, Keyur P Patel, Philip A Thompson, et al.Cancer|January 31, 2020
Long-term results of a phase 2 trial of nilotinib 400 mg twice daily in newly diagnosed patients with chronic-phase chronic myeloid leukemiaLucia Masarova, Jorge E Cortes, Keyur P Patel, et al.BMC Cancer|February 2, 2020
Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutationsRoberto Ruiz-Cordero, Junsheng Ma, Abha Khanna, et al.Archives of Pathology & Laboratory Medicine|January 25, 2021
Factors Impacting Clinically Relevant RNA Fusion Assays Using Next-Generation SequencingNisha S Ramani, Keyur P Patel, Mark J Routbort, et al.Pageof 23